Page last updated: 2024-08-26

bosentan anhydrous and Alcoholic Cirrhosis

bosentan anhydrous has been researched along with Alcoholic Cirrhosis in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bodin, F; Dingemanse, J; Popescu, G; van Giersbergen, PL1
Gerbes, AL; Gülberg, V; Kuntzen, C1
Halank, M; Hoeffken, G; Hoeper, MM; Marx, C; Niedermeyer, J; Schauer, J; Seyfarth, HJ; Winkler, J1
Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S; Schiemanck, S; Schmeisser, A1
Stähler, G; von Hunnius, P1

Trials

1 trial(s) available for bosentan anhydrous and Alcoholic Cirrhosis

ArticleYear
Influence of mild liver impairment on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:1

    Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bosentan; Endothelin Receptor Antagonists; Female; gamma-Glutamyltransferase; Humans; L-Lactate Dehydrogenase; Liver; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides

2003

Other Studies

4 other study(ies) available for bosentan anhydrous and Alcoholic Cirrhosis

ArticleYear
Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
    Gastroenterology, 2005, Volume: 128, Issue:1

    Topics: Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome

2005
Bosentan therapy for portopulmonary hypertension.
    The European respiratory journal, 2005, Volume: 25, Issue:3

    Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Oxygen Consumption; Retrospective Studies; Sulfonamides; Treatment Outcome

2005
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
    Wiener medizinische Wochenschrift (1946), 2005, Volume: 155, Issue:15-16

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Male; Recurrence; Sulfonamides; Time Factors

2005
Successful treatment of portopulmonary hypertension with bosentan: case report.
    European journal of clinical investigation, 2006, Volume: 36 Suppl 3

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Echocardiography; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome; Vasodilation

2006